[(1-methyl-1H-pyrrol-2-yl)methyl][2-(morpholin-4-yl)ethyl]amine
|
|
Sicherheit
[(1-methyl-1H-pyrrol-2-yl)methyl][2-(morpholin-4-yl)ethyl]amine Chemische Eigenschaften,Einsatz,Produktion Methoden
[(1-methyl-1H-pyrrol-2-yl)methyl][2-(morpholin-4-yl)ethyl]amine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
[(1-methyl-1H-pyrrol-2-yl)methyl][2-(morpholin-4-yl)ethyl]amine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 5)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
PHARMEKS Ltd. | -- |
sales@pharmeks.com | Finland | 6349 | 50 |
Specs | -- |
info@specs.net | The Netherlands | 6833 | 70 |
Interbioscreen Ltd. | -- |
screen@ibscreen.chg.ru | Finland | 6176 | 60 |
Princeton BioMolecular Research, Inc. | -- |
info@princetonbio.com | United States | 6934 | 51 |
UkrOrgSynthesis Ltd. | -- |
y.barysheva@ukrorgsynth.com | Ukraine | 6230 | 38 |
- [(1-methyl-1H-pyrrol-2-yl)methyl][2-(morpholin-4-yl)ethyl]amine
- N-[(1-methyl-1H-pyrrol-2-yl)methyl]-N-[2-(4-morpholinyl)ethyl]amine
- 4-Morpholineethanamine, N-[(1-methyl-1H-pyrrol-2-yl)methyl]-
- 289488-59-1